# Biological heart and brain ageing in subjects with cardiovascular diseases

## TL;DR

This study explores how cardiovascular diseases affect brain and heart aging using brain and heart age gap biomarkers in UK Biobank data.

## Contribution

It introduces a novel approach combining brain age gap (BAG) and heart age gap (HAG) to assess biological aging in cardiovascular disease groups.

## Key findings

- 24 out of 36 cardiovascular disease groups showed significant differences in BAG and HAG compared to healthy subjects.
- Some diseases like hypotension and cardiac conduction disorders showed sex-specific differences in BAG and HAG.
- No strong correlation was found between BAG and HAG within disease groups, suggesting heterogeneous aging processes.

## Abstract

The heart-brain axis hypothesis suggests a bidirectional connection between the brain and the heart with relevant implications in health and disease. Cardiovascular diseases have been empirically linked to an increased risk of neurological diseases. However, it remains unclear to what extent different cardiovascular diseases affect brain health quantitatively across subjects and if that is associated with the extent the heart is affected by a disease. Therefore, this study aims to explore how cardiovascular diseases affect biological ageing of the brain and heart by quantifying the brain age gap (BAG) and the heart age gap (HAG) and relating the two to each other.

This study used data from UK Biobank participants with available T1-weighted brain magnetic resonance imaging (MRI) scans, cardiac MRI-derived features, as well as pulse wave analysis cardiac measurements. This dataset included 7,500 healthy females and 6,684 healthy males. The data from healthy subjects was used to train biological brain age prediction machine learning models. For BAG computation, a convolutional neural network was trained based on the MRI data, while a CatBoost model was trained for HAG analyses based on the tabulated cardiac features. Individuals with cardiovascular diseases (F = 2,304, M = 2,925) in the UK Biobank were categorized using Phecodes and split based on sex and used to calculate the HAG and BAG for further analyses.

In 36 sex-specific cardiovascular disease groups, 24 showed significant differences from healthy subjects in the BAG and HAG distributions, whereas no strong correlations between the BAG and HAG distributions within disease groups were found. However, some diseases, such as hypotension and cardiac conduction disorders, showed sex-specific differences.

This study demonstrates that the combined use of HAG and BAG biomarkers provides a more comprehensive understanding of the interplay between cardiovascular and neurological ageing. The significant differences observed in disease groups, while lacking a strong correlation between the BAG and HAG, questions the generalizability of the heart-brain axis theory with respect to age gap biomarkers, suggesting potentially heterogeneous aging processes of the two systems that warrant further investigation in future work.